Literature DB >> 22717470

Maximising the potential of voluntary counselling and testing for HIV: sexually transmitted infections and HIV epidemiology in a population testing for HIV and its implications for practice.

Hsiu Wu1, Pei-Ying Wu, Shu-Ying Li, Sui-Yuan Chang, Wen-Chun Liu, Cheng-Hsin Wu, Yi-Cheng Lo, Chia-Yin Hsieh, Hsin-Yun Sun, Chien-Ching Hung.   

Abstract

OBJECTIVES: This study aimed to describe the epidemiology of HIV infection and sexually transmitted infections (STIs) among persons who attended voluntary counselling and testing (VCT) service for HIV and to assess whether the VCT programme reached the right population at risk in Taiwan.
METHODS: From 2006 to 2010, questionnaire interview, integrated pretesting and post-testing counselling, followed by serological tests for HIV, Treponema pallidum and Entamoeba histolytica were performed for all VCT clients; additional tests for Chlamydia trachomatis and Neisseria gonorrhoeae using PCR assays of urine specimens were provided when the assays became available in two periods.
RESULTS: During the study period, 10 198 VCT attendances occurred in 6863 clients, in whom 1685 (24.6%) had re-attendances. Male clients, men who have sex with men and clients with one-night stand and casual sexual partners were more likely to re-attend VCT service in the next 12 months. The overall STI prevalence was 3.5% for HIV infection, 2.2% syphilis, 1.0% amoebiasis, 4.7% chlamydia and 0.7% gonorrhoea. In logistic regression model, men who have sex with men were consistently independently associated with HIV infection, syphilis and amoebiasis. Among the repeaters, the incidence rate of HIV infection and syphilis was 3.4 and 1.6 per 100 person-years of follow-up, respectively. In Cox regression analysis, clients who used illicit non-injection recreational drugs and who practiced unprotected anal sex were at significantly higher risk of acquiring HIV infection and syphilis.
CONCLUSIONS: With higher rates of re-attendances and STIs, the VCT programme reached the population most at risk for HIV and STIs compared with other screening programmes in Taiwan. The potential of VCT programme can be maximised in the prevention and control of HIV infection and STIs by providing tests for more STIs and counselling to avoid use of recreational drugs and to promote safe sex.

Entities:  

Mesh:

Year:  2012        PMID: 22717470     DOI: 10.1136/sextrans-2011-050354

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  10 in total

1.  Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan.

Authors:  Jen-Chih Tsai; Chien-Ching Hung; Sui-Yuan Chang; Wen-Chun Liu; Cheng-Hsin Wu; Yi-Ching Su; Pei-Ying Wu; Yu-Zhen Luo; Lan-Hsin Chang; Hsin-Yun Sun; Shan-Chwen Chang
Journal:  BMJ Open       Date:  2015-10-13       Impact factor: 2.692

2.  Prevalent and incident HIV diagnoses among Entamoeba histolytica-infected adult males: a changing epidemiology associated with sexual transmission--Taiwan, 2006-2013.

Authors:  Yi-Chun Lo; Dar-Der Ji; Chien-Ching Hung
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

3.  Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up?

Authors:  Anne Lallemand; Viviane Bremer; Klaus Jansen; Stine Nielsen; Dieter Münstermann; Andreas Lucht; Carsten Tiemann
Journal:  BMC Infect Dis       Date:  2016-10-26       Impact factor: 3.090

4.  Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey.

Authors:  Yi-Chieh Lee; Sui-Yuan Chang; Kuan-Yin Lin; Lan-Hsin Chang; Wen-Chun Liu; Cheng-Hsin Wu; Hsin-Yun Sun; Chien-Ching Hung; Shan-Chwen Chang
Journal:  BMJ Open       Date:  2017-10-16       Impact factor: 2.692

5.  Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study.

Authors:  Yasuaki Yanagawa; Mami Nagashima; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka; Keiko Yokoyama; Takayuki Shinkai; Kenji Sadamasu; Koji Watanabe
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

6.  Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.

Authors:  Hsin-Yun Sun; Chien-Yu Cheng; Nan-Yao Lee; Chia-Jui Yang; Shiou-Haur Liang; Mao-Song Tsai; Wen-Chien Ko; Wen-Chun Liu; Pei-Ying Wu; Cheng-Hsin Wu; Hsi-Hsun Lin; Chien-Ching Hung
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

7.  Comparison of serological response to doxycycline versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients: a multi-center observational study.

Authors:  Jen-Chih Tsai; Yu-Huei Lin; Po-Liang Lu; Ni-Jiin Shen; Chia-Jui Yang; Nan-Yao Lee; Hung-Jen Tang; Yuag-Meng Liu; Wen-Chi Huang; Chen-Hsiang Lee; Wen-Chien Ko; Yen-Hsu Chen; Hsi-Hsun Lin; Tun-Chieh Chen; Chien-Ching Hung
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

8.  The emerging HIV epidemic among men who have sex with men in Taiwan.

Authors:  Yen-Fang Huang; Chang-Hsun Chen; Feng-Yee Chang
Journal:  J Formos Med Assoc       Date:  2013-01-08       Impact factor: 3.282

9.  Towards the first 90: impact of the national HIV self-test program on case finding and factors associated with linkage to confirmatory diagnosis in Taiwan.

Authors:  Yen-Fang Huang; Yu-Ching Huang; Yi-Chun Lo; Carl Latkin; Hsun-Yin Huang; Chia-Chi Lee; Li-Chern Pan; Hsu-Sung Kuo
Journal:  J Int AIDS Soc       Date:  2022-03       Impact factor: 5.396

10.  Sexually transmitted diseases among psychiatric patients in Brazil.

Authors:  Maria Rita Teixeira Dutra; Lorenza Nogueira Campos; Mark Drew Crosland Guimarães
Journal:  Braz J Infect Dis       Date:  2013-08-06       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.